EGFR and cancer: The high-risk group was enriched in endocytosis, cancer pathways, regulation of actin cytoskeleton, and ERBB signaling pathways, and the low-risk group was enriched primarily in bile acid biosynthesis, drug metabolism cytochrome P450, fatty acid metabolism, retinol metabolism, and metabolism of xenobiotics by cytochrome P450.